Introduction
High glucose associated with diabetes mellitus (DM) causes central and peripheral nervous system complications (Holder et al., 1997; Edwards et al., 2008) due to cellular oxidative stress (Radi et al., 2014; Yan et al., 2014) . Specifically, oxidative stress, due to glucose oxidation or reduced capacity of the antioxidant defense system (Edwards et al., 2008; Kamboj et al., 2010) , can trigger neuronal cell death, a major cause of the neuropathology associated with DM (de la Monte and Tong, 2014) . Therefore, local neuromodulators serve important roles in mediating or guarding against exacerbation of these neurotoxic effects of high glucose.
Endothelin (ET), a neuromodulator peptide that exists in three isoforms ET-1, 2 and 3 (Inoue et al., 1989) , activates two ET receptor subtypes, ET-A and ET-B, with varying degrees of selectivity (Arai et al., 1990) . Although high glucose increases ET level in vivo (Schneider et al., 2002) or decreases its level in in-vitro models (Ward and Ergul, 2016) , the role of ET in high glucose-evoked neurotoxicity remains elusive due to controversial reports on ET effects on the nervous system. For example, ET activation of the ET-A receptor is implicated in cerebral ischemia/reperfusion injury (Matsuo et al., 2001) , in other reports ET confers neuroprotection through both ET-A and B receptors (Laziz et al., 2011) . It is possible, therefore, that ET alterations of the functions of redox enzymes and cell survival depend on the pathological conditions.
Catalase is generally recognized as antioxidant enzyme that confers cellular protection (Spitz et al., 1987) . Similarly, hemeoxygenase (HO) exerts protective effect against cellular injury (Maines, 1997) . Of the 3 HO isozymes, HO-1 is inducible by noxious stimuli and oxidative stress (Hartsfield et al., 1997) . It is imperative to note, however, that chronic HO-1 induction may contribute to deleterious iron aggregation and mitochondrial dysfunction in neurodegenerative disorders (Schipper, 2000) . Despite a shared ability of ET and HO-1 to guard against or contribute to cellular derangements under different settings, it is not known if both molecules will exert the This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on February 8, 2017 as DOI: 10.1124 at ASPET Journals on February 10, 2017 jpet.aspetjournals.org Downloaded from same function in high glucose-induced neurotoxicity. Interestingly, both ET and HO-1 share the ability to activate a common downstream signaling product, the extracellular signal-regulated kinases (ERK1/2), and to modulate reactive oxygen species (ROS) and apoptosis (Wu-Wong et al., 2000; Chen et al., 2016) . Despite this knowledge, there are no studies on the effect of ET on HO-1 expression in neurons exposed to high glucose concentrations. Notably, a very recent correlative link between a reduction in ET-1 and high glucose-evoked neuroinflammation in vitro inferred a neuroprotective role for ET-1 (Ward and Ergul, 2016) . Collectively, current evidence does not unequivocally support a neuroprotective role for ET-1 or ET-3 against high glucose evoked toxicity, and the implicated neurochemical mechanisms remain unknown.
The first aim of the present study was to determine if ET contributes to, or guards against, high glucose-induced neurotoxicity in cultured PC12 cells. Next, we tested the hypothesis that ET alleviates high glucose-evoked neurotoxicity via an ET-B receptor dependent up-regulation of HO-1 and enhancement of catalase activity. PC12 cells were used in our studies because they assume neuronal phenotype when exposed to nerve growth factor (Tischler and Greene, 1978) , and constitute an established model for studying mechanisms of adverse neuronal effects caused by high glucose levels such as apoptosis and ROS generation (Lelkes et al., 2001) . Cell viability, redox status and neurochemical responses were investigated in PC12 cells exposed to high or normal glucose level in the presence or absence of ET-1 or ET-3 and additional studies were conducted in the presence of selective ET-A or ET-B receptor blockade under high glucose condition.
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Materials and Methods
Drugs
ET-1, ET-3, BQ123, BQ788 were purchased from sigma-Aldrich (St. Louis, MO).
Cell culture and treatment
Rat pheochromocytoma cells (PC12 cells) (ATCC, Rockville, MD) were cultured in RPMI 1640 medium supplemented with horse serum (15%), fetal bovine serum (2.5%), penicillin (100 U/ml) and streptomycin (100 U/ml), at 37 o C with saturated air containing 5% CO 2 . Cells were passaged in Corning Cell Bind flasks for proper adherence then differentiated by treating with NGF (50 ng/ml) for 48 hrs. to initiate neuronal differentiation, and culture media was changed every 2 days as in our previous studies (Zhang et al., 2001) . The differentiated cells were examined microscopically and the differentiated cells were used in subsequent experiments.
Determination of cell viability
In order to establish the concentration-dependent neurotoxicity caused by glucose in our model system, PC12 cells were seeded at 50,000 cells/ml in 96-well plate in RPMI 1640 medium with serum for 48 hrs. (90% confluence), then treatments were started in low serum RPMI 1640 (0.5% FBS and 1% antibiotic-antimycotic) with normal (11.11 mM) or escalated (25, 50, 100, 150 mM) glucose concentrations for another 48 hrs. At the end of the incubation period, cell viability was measured by MTS cell proliferation assay kit (Promegra, Madison, WI) with absorbance measured at 495 nm in accordance with manufacturer's instructions. The 100 mM glucose concentration was selected for the subsequent studies. Second, to investigate the effect of ET on cell viability, cells were treated with ET-1 (10 -14 -10 -6 M), ET-A blocker (BQ123, 10 -12 -10 -6 M) or ET-B blocker (BQ788, 10 -12 -10 -6 M) in low serum RPMI 1640 with normal (11.11 mM) or high (100 
Caspase 3/7 activity assay
The same experimental protocol described above was followed under this experiment.
Cultured cells were plated in white-walled 96-well plate and incubated for 48 hrs. Media containing the appropriate concentration of different agents was added to the cells for 48 hrs.
After that, 100 µl of Caspase-Glo 3/7 reagent (Promega, Madison, WI) was then added to each well as directed by the manufacturer and luminescence was measured in a luminometer.
Luminescence is proportional to the caspase activity.
ROS measurement
We used two methods to measure oxidative stress in cultured cells, the chloromethyl-2', 7' dichlorodihydrofluorescein diacetate (CM-H2DCFDA) (Life Technologies, Grand Island, NY) and the dihydroethidium methods. Under oxidative stress conditions, CM-H2DCFDA is oxidized to 2', 7' dichlorofluorescein (DCF). Cells were loaded with 5 mM CM-H2DCFDA (Molecular Probes, Invitrogen) in phenol red-free, low serum medium containing 11.11, 100 and 150 mM glucose for 48 hrs. Cells were then trypsinized and DCF fluorescence was measured using an Accuri C6 flow cytometer (BD Accuri Cytometers, Ann Arbor, MI) at an excitation wavelength of 488 and a 533 nm emission filter.
Moreover, the effect of ET-1 or ET-3 (1 µM for 48 hrs.) on ROS levels was studied in cultured PC12 cells grown in normal (11.11 mM) or high (100 mM) glucose medium using the DCFH-DA method. The oxidation-sensitive fluoroprobe DCFH-DA was used as a substrate for measuring intracellular ROS. Quantification was conducted by examining fluorescence intensity using a microplate fluorescence reader at excitation 485 nm/emission 530 nm. Kinetic readings were (McGee and Abdel-Rahman, 2012) . Further, we used mannitol (100 mM) as osmotic control for high glucose (100 mM) in accordance with reported studies (Sharifi et al., 2009 ).
Dihydroethidium staining for superoxide detection
To validate the findings with the DCF method and in accordance with current recommendations that at least 2 different methods are needed for quantifying ROS generation (Griendling et al., 2016) , PC12 cells were incubated with 10 µM dihydroethidium (DHE) (Molecular Probes, Grand Island, NY) at 37°C in the presence of 5% CO 2 in a moist chamber for 30 min.
Positive and negative controls were used to validate the assay. Images were visualized with a Zeiss LSM 510 microscope. Quantification was conducted using Image J Software (National Institutes of Health) and changes in total fluorescence intensity, normalized to control, were calculated as reported (Collin et al., 2007) .
We elucidated the implicated ET receptor subtype by investigating the effects of 48-hrs.
treatment with ET-1 or ET-3 (1 µM) on PC12 cell viability (MTS) and apoptosis (caspase-3/7) and ROS level, under high (100 mM) glucose conditions, in the absence or presence of a selective ET-A (BQ123, 1 µM) or ET-B (BQ788, 1 µM) blocker. The selective blocker or its vehicle was added to the incubation medium 4 hrs. before ET-1, ET-3 or their vehicle.
Western blot analysis
The method described in our previous studies was employed to determine the effect of high (100 mM) glucose level expression level of ET-A, ET-B, HO-1, nNOS and ERK1/2 (Rezq and Abdel-Rahman, 2016) in the absence or presence of ET-1 or ET-3. In these experiments, PC12
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The mixture was centrifuged at 3000 rpm for 5 min at 4 °C. The supernatant was separated and assayed for protein content (Bradford assay, Bio-Rad). Catalase activity was determined calorimetrically in 10 μg protein using the Catalase Assay Kit (catalog no. CAT-100, SigmaAldrich, St. Louis, MO) according to the manufacturer's instructions by spectrophotometry.
Data analysis and statistics
Data were collected from three independent experiments, and are expressed as mean ± standard error of mean (SEM). Statistical analysis was conducted by using one-way or repeated measures analysis of variance for multiple comparisons followed by Tukey's post hoc test. Prism 5.0 software (Graphpad software Inc., San Diego, CA) was used to perform statistical analysis, P < 0.05 was considered significant.
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Results
ET-1 and ET-3 abrogated high glucose-induced neurotoxicity.
Exposure of PC12 cells to higher than normal glucose for 48 hrs. caused concentration dependent reductions in cell viability (Fig. 1A ). While incubation with ET-1 (10 -14 -10 -6 M) or ET-3 (10 -6 M) for 48 hrs. had no effect on net cell number of PC12 cells cultured in normal glucose ( Fig. 1B and 1C), ET-1 (10 -6 M) abrogated the high (100 mM) glucose-evoked reduction in cell viability (Fig. 1D ). Therefore, we selected the 100 mM glucose and the 10 -6 M ET-1 or ET-3 concentrations for subsequent experiments. Neither selective ET-A (BQ123) nor ET-B (BQ788) antagonist (10 -12 to 10 -6 M) influenced PC12 cells viability in normal or in high (100 mM) glucose medium ( Fig. 1E and 1F ). However, BQ123 (10 -6 M) or BQ788 (10 -6 M) abrogated the neuroprotective effect of ET-1 (10 -6 M) against high glucose (100 mM)-evoked neurotoxicity ( (Fig. 3A) .
ET reversed HO-1 induction and catalase inhibition caused by high glucose.
High glucose (100 mM) concentration significantly decreased ET-A receptor expression and this inhibition was not affected by ET-1 or ET-3 in presence or absence of ET-A or ET-B antagonist (Fig. 6A) . On the other hand, ET-1 or ET-3 reversed high glucose induced elevation in ET-B receptor expression ( Fig. 6C ) and selective ET-B blockade (BQ788) abrogated the effect of ET-1 (Fig. 6C) . Also, high glucose (100 mM) caused significant (P < 0.05) HO-1 induction (Fig. 7 ), ERK1/2 phosphorylation ( Fig. 8 ) and inhibition of catalase activity (Fig. 9A) . Notably, the parallel increases in p-ERK1/2 and total ERK1/2 expression under high glucose conditions (Table 1) precluded appropriate elucidation of the role of ET-1 or ET-3 in ERK1/2 phosphorylation in our model system. Therefore, we normalized p-ERK1/2 to GAPDH in these studies (Fig. 8 ). These neurochemical effects were reversed by ET-1 or ET-3 in an ET-B dependent manner because selective ET-B, but not ET-A, blockade abrogated the favorable effects of ET-1 or 8 and 9B). Further, under high glucose conditions, ET-1 or ET-3 enhanced (P < 0.05) n-NOS phosphorylation and this effect was abrogated by ET-A or ET-B blockade (Fig. 10 ).
This article has not been copyedited and formatted. The final version may differ from this version. 2002; Ward and Ergul, 2016). We utilized three ROS and two cell death/survival assays in accordance with recent guidelines that at least two different assays are needed for ROS (Griendling et al., 2016) , and cell death (Mills et al., 1995) . Collectively, our initial findings are consistent with an important role for oxidative stress in the high glucose-evoked neurotoxicity in cultured neuronal cells (Lelkes et al., 2001; Vincent et al., 2005; Shi et al., 2015) . It should be noted that mannitol (100 mM) used as osmotic control for high glucose had no effect on ROS (Fig. 3) , cell viability or apoptosis (Sharifi et al., 2009) , which rules out hyperosmolar conditions as a cause for high glucose-evoked oxidative stress and cell toxicity in PC12 cells.
While several lines of evidence implicate ET in diabetes related vascular complications (Ergul, 2011), few controversial findings are reported on ET role in diabetes-induced neurological impairment (Demir et al., 2015; Ward and Ergul, 2016) . Given the lack of studies on ET effects on PC12 cell function, and the paucity of such studies in other neuronal model systems, we considered the possibility that ET-1 exerts a biphasic effect on the redox status and cell survival.
To address this question, we investigated the effect of ET-1 on the viability of cells incubated in normal or high glucose media in concentrations (10 -14 to 10 -6 M) used in studies on ET receptor signaling in PC12 cells cultured in normal glucose medium (Takekoshi et al., 2002; Gardner et al., 2005) ; no data on cell survival or ROS level were generated in these studies. We investigated the effect of ET-1 or ET-3 on catalase activity and HO-1 expression because of their antioxidant roles (Spitz et al., 1987) . First, consistent with catalase antioxidant biology (Chen et al., 2005) , the inhibition of its activity (Fig. 9A ) might explain, at least partly, the high glucose-evoked neurotoxicity. This notion is supported by the ET-1 or ET-3 restoration of catalase activity ( Fig. 9A ) and the alleviation of the neurotoxicity (Fig. 1D) . Second, an unexpected induction of the antioxidant enzyme HO-1 (Fig. 7) might be explained by HO-1 mediation of chronic oxidative stress and neurodegeneration in Alzheimer and Parkinson's diseases (Schipper et al., 1995; Frankel et al., 2000; Schipper, 2004; Calabrese et al., 2006) . Further, the ability of ET-1 or ET-3 to enhance n-NOS phosphorylation ( (Shichiri et al., 1998) or phospholipase A2 (Sellmayer et al., 1996) .
Here, we present the first evidence that high glucose caused HO-1 induction and ERK1/2 phosphorylation, and that ET-1 or ET-3 reversed these neurochemical responses (Figs. 7 and 8 ).
Nonetheless, it was important to determine if the ET-1 or ET-3 reversal of the divergent effects of high glucose on catalase and HO-1 were ET receptor-mediated and to determine the implicated ET receptor subtype(s).
Our data suggest that the ET-B, with a lesser contribution of the ET-A, receptor mediates the neuroprotective effect of ET-1 or ET-3 because: (i) Selective ET-A (BQ123) or ET-B (BQ788)
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